Xponance Inc. Trims Position in Revvity, Inc. (NYSE:RVTY)

Xponance Inc. lessened its stake in shares of Revvity, Inc. (NYSE:RVTY) by 3.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,043 shares of the company’s stock after selling 522 shares during the period. Xponance Inc.’s holdings in Revvity were worth $1,902,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. Wealth Enhancement Advisory Services LLC raised its holdings in Revvity by 2.4% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,214 shares of the company’s stock valued at $470,000 after buying an additional 100 shares during the period. HB Wealth Management LLC raised its holdings in Revvity by 4.6% in the 4th quarter. HB Wealth Management LLC now owns 2,380 shares of the company’s stock valued at $266,000 after buying an additional 104 shares during the period. Signaturefd LLC raised its holdings in Revvity by 6.8% in the 4th quarter. Signaturefd LLC now owns 1,668 shares of the company’s stock valued at $186,000 after buying an additional 106 shares during the period. Westside Investment Management Inc. raised its holdings in Revvity by 0.8% in the 4th quarter. Westside Investment Management Inc. now owns 14,363 shares of the company’s stock valued at $1,603,000 after buying an additional 108 shares during the period. Finally, Coldstream Capital Management Inc. raised its holdings in Revvity by 5.1% in the 3rd quarter. Coldstream Capital Management Inc. now owns 2,247 shares of the company’s stock valued at $286,000 after buying an additional 110 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Insider Activity at Revvity

In related news, insider Joel S. Goldberg sold 15,170 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the sale, the insider now directly owns 33,400 shares of the company’s stock, valued at $4,232,782. The trade was a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Tajinder S. Vohra sold 5,492 shares of the business’s stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the completion of the sale, the insider now directly owns 19,652 shares of the company’s stock, valued at approximately $2,295,550.12. This trade represents a 21.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.60% of the stock is owned by corporate insiders.

Revvity Price Performance

Revvity stock opened at $107.18 on Friday. The stock has a market cap of $12.88 billion, a P/E ratio of 48.50, a price-to-earnings-growth ratio of 3.82 and a beta of 1.06. The company has a fifty day simple moving average of $116.44 and a 200-day simple moving average of $117.54. Revvity, Inc. has a 12-month low of $97.32 and a 12-month high of $129.50. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the previous year, the company posted $1.25 earnings per share. Equities analysts expect that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be given a $0.07 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.26%. Revvity’s dividend payout ratio (DPR) is presently 12.67%.

Wall Street Analyst Weigh In

RVTY has been the topic of a number of recent research reports. Raymond James reiterated an “outperform” rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Barclays boosted their price target on shares of Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. KeyCorp boosted their price target on shares of Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Sanford C. Bernstein lowered shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target on the stock. in a research note on Friday, January 10th. Finally, Bank of America upgraded shares of Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price target on the stock in a research note on Friday, December 13th. Four investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $136.25.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.